SciELO - Scientific Electronic Library Online

vol.110 issue11Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Española de Enfermedades Digestivas

Print version ISSN 1130-0108


NUNEZ-ORTIZ, Andrea et al. Topical mesalazine as a cause of Stevens-Johnson syndrome. Rev. esp. enferm. dig. [online]. 2018, vol.110, n.11, pp.736-738. ISSN 1130-0108.

Mesalazine is a drug routinely used in ulcerative colitis and usually has few side effects. There have been reports of uncommon cases of severe mucocutaneous damage, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), induced by salicylates. It is important to diagnose these promptly due to the high morbidity and mortality rates. We describe the case of a 46-year-old female with ulcerative proctitis, who developed SJS following topical mesalazine use. The lesions responded well to intravenous corticosteroids after discontinuation of the drug.

Keywords : Mesalazine; Stevens-Johnson syndrome; Toxic epidermal necrolysis.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )